Drew N. Rosenbaum, M.D.

The purpose of this study is to evaluate the effect of  rilonacept added to standard therapy on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after six months of therapy.

Aims, purpose, or objectives:

1. Develop a retrospective registry of patients with cardiac sarcoidosis
2. Develop a prospective registry of patients with cardiac sarcoidosis
3. Understand the natural history of cardiac sarcoidosis through evaluation of outcomes of patients in the registry
4. Determine risk factors for sarcoid involvement of the heart
5. Evaluate outcomes of patients both treated and untreated with cardiac sarcoidosis
6. Understand the complications of untreated and treated cardiac sarcoidosis

The purpose of this study is to determine if HgbA1c will underestimate average glucose obtained over a 3-month period in a cohort of diabetic LVAD-supported patients. Also, to see if continous glucose monitor: (CGM) data will facilitate improved antihyperglycemic decision making in diabetic patients.

The purpose of this study is to evaluate the effectiveness of HeartMate 3 ® dLVAD normal and abnormal pump operations data on clinical practice applications when utilizing downloadable pump data analyses at several time points following implantation: discharge from the intensive care unit (ICU), +/- 3 days of discharge from the hospital (over a week post implant), 3 months post dLVAD, 6 months post dLVAD, and 12 months post dLVAD. 

The purpose of this study is to useconductance catheters and BiV PV loop software to generate biventricular PV loops for the purposes of research assessment of hemodynamics.

Aims, purpose, or objectives:

1. Develop a retrospective registry of patients with cardiac sarcoidosis
2. Develop a prospective registry of patients with cardiac sarcoidosis
3. Understand the natural history of cardiac sarcoidosis through evaluation of outcomes of patients in the registry
4. Determine risk factors for sarcoid involvement of the heart
5. Evaluate outcomes of patients both treated and untreated with cardiac sarcoidosis
6. Understand the complications of untreated and treated cardiac sarcoidosis